NO982927L - Biologisk aktive benzotiazolon etanaminer - Google Patents

Biologisk aktive benzotiazolon etanaminer

Info

Publication number
NO982927L
NO982927L NO982927A NO982927A NO982927L NO 982927 L NO982927 L NO 982927L NO 982927 A NO982927 A NO 982927A NO 982927 A NO982927 A NO 982927A NO 982927 L NO982927 L NO 982927L
Authority
NO
Norway
Prior art keywords
ethanamines
biologically active
benzothiazolone
active benzothiazolone
halogen
Prior art date
Application number
NO982927A
Other languages
English (en)
Other versions
NO982927D0 (no
Inventor
Roger Bonnert
Roger Brown
Peter Cage
David Cheshire
Francis Ince
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO982927L publication Critical patent/NO982927L/no
Publication of NO982927D0 publication Critical patent/NO982927D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Forbindelser av formel (I) (CH2)p-S02-(CH2)q-0-(CH2)r-X hvor X representerer naftyl eventuelt substituert med alkyl eller halogen; og p, q og r uavhengig representerer 2 eller 3, og farmasøytisk akseptable salter derav; fremgangsmåter for deres fremstilling og metoder for deres anvendelse.
NO982927A 1995-12-23 1998-06-23 Biologisk aktive benzotiazolon etanaminer NO982927D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526511.2A GB9526511D0 (en) 1995-12-23 1995-12-23 Pharmaceutically active compounds
PCT/SE1996/001650 WO1997023470A1 (en) 1995-12-23 1996-12-13 Biologically active benzothiazolone ethanamines

Publications (2)

Publication Number Publication Date
NO982927L true NO982927L (no) 1998-06-23
NO982927D0 NO982927D0 (no) 1998-06-23

Family

ID=10786064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982927A NO982927D0 (no) 1995-12-23 1998-06-23 Biologisk aktive benzotiazolon etanaminer

Country Status (27)

Country Link
US (1) US5929100A (no)
EP (1) EP0918760B1 (no)
JP (1) JP2000502681A (no)
KR (1) KR19990076688A (no)
CN (1) CN1072214C (no)
AR (1) AR005008A1 (no)
AT (1) ATE209638T1 (no)
AU (1) AU704506B2 (no)
BR (1) BR9612234A (no)
CA (1) CA2238877A1 (no)
CZ (1) CZ288704B6 (no)
DE (1) DE69617472D1 (no)
EE (1) EE03440B1 (no)
GB (1) GB9526511D0 (no)
HU (1) HUP9900100A3 (no)
IL (2) IL142502A0 (no)
IS (1) IS4759A (no)
MX (1) MX9804828A (no)
NO (1) NO982927D0 (no)
NZ (1) NZ325500A (no)
PL (1) PL327475A1 (no)
RU (1) RU2177476C2 (no)
SK (1) SK82098A3 (no)
TR (1) TR199801196T2 (no)
TW (1) TW401411B (no)
WO (1) WO1997023470A1 (no)
ZA (1) ZA9610354B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (fr) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2
AR040962A1 (es) * 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
CA2543858C (en) 2003-11-21 2014-04-15 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
AU2009260899B2 (en) 2008-06-18 2012-02-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
DK514585A (da) * 1984-11-08 1986-05-09 Syntex Inc Aminoethylanilinderivater
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
US5648370A (en) * 1990-11-20 1997-07-15 Astra Pharmaceuticals Limited 7-(2-aminoethyl) benzothiazolones
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
CA2238877A1 (en) 1997-07-03
HUP9900100A2 (hu) 1999-05-28
GB9526511D0 (en) 1996-02-28
EE9800193A (et) 1998-12-15
CN1211242A (zh) 1999-03-17
HUP9900100A3 (en) 2001-10-29
PL327475A1 (en) 1998-12-07
AU704506B2 (en) 1999-04-22
CZ288704B6 (cs) 2001-08-15
EP0918760A1 (en) 1999-06-02
TW401411B (en) 2000-08-11
IS4759A (is) 1998-05-27
ZA9610354B (en) 1997-06-23
EE03440B1 (et) 2001-06-15
NZ325500A (en) 1999-01-28
JP2000502681A (ja) 2000-03-07
EP0918760B1 (en) 2001-11-28
IL142502A0 (en) 2002-03-10
IL124998A0 (en) 1999-01-26
BR9612234A (pt) 1999-07-13
TR199801196T2 (xx) 1998-10-21
AU1402597A (en) 1997-07-17
ATE209638T1 (de) 2001-12-15
KR19990076688A (ko) 1999-10-15
MX9804828A (es) 1998-09-30
WO1997023470A1 (en) 1997-07-03
AR005008A1 (es) 1999-04-07
NO982927D0 (no) 1998-06-23
CN1072214C (zh) 2001-10-03
SK82098A3 (en) 1998-11-04
CZ168498A3 (cs) 1998-09-16
US5929100A (en) 1999-07-27
RU2177476C2 (ru) 2001-12-27
DE69617472D1 (de) 2002-01-10

Similar Documents

Publication Publication Date Title
NO996108L (no) 9-oksinerytromycinderivater
FI943142A (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
DK142084D0 (da) N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
ES531121A0 (es) Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos
ES2048109B1 (es) Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
FI893701A (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
FI893426A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten BU-3608-johdannaisten ja niiden suolojen valmistamiseksi
DE3564684D1 (en) Tetrahydrothienopyridines, process for their preparation and their pharmaceutical application
DK529585A (da) N-(6-methoxy-5-(perflouralkyl)-1-naphtholyl)-n-methylglyciner og deres thionaphthoyl analoge, deres fremstilling og anvendelse som laegemidler
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
DE3465993D1 (en) Indole derivatives, their preparation and their therapeutical application
NO20013601L (no) Nye morfolinobenzamidsalter
NO179445C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksysulfonylkarbamater
EE03083B1 (et) Reniini inhibeerivad N-(2-amino-2-oksüetüül)butaandiamiidi derivaadid, meetodid nende saamiseks ja neid sisaldav ravim
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
DK104388A (da) Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
NO922094L (no) Heksapeptider med sulfatestergrupper

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application